Treatment of overdosage must be symptomatic at this time, as clinical studies with prostaglandin antagonists have not progressed to the point where recommendations may be made. If evidence of excessive side-effects appears, the frequency of administration should be decreased or administration discontinued.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
